Earnings Live: High Expectations For Synopsys (SNPS)

the elephant in the room is China. With U.S. regulators reportedly halting EDA software sales to Chinese firms like Huawei, Synopsys is now staring down a direct hit to roughly 16% of its business, triggering a sharp 10.5% decline in shares prior to earnings. Although Synopsys made no specific comments about China in the Q2 release, the issue now casts a long shadow over forward estimates and investor sentiment.

The stock is now up closer to 2% after-hours, clawing back some of the drop minutes before earnings.

Synopsys beat Q2 estimates across the board and reaffirmed strong full-year guidance, highlighting continued AI-driven strength and resilience across design markets.

However the stock is in standstill after President Trump’s order to stop selling to China. The stock ended 10.6% down but up .86% after earnings.

Revenue reached $1.604 billion, up 10% year-over-year and above the midpoint of guidance. Non-GAAP EPS was $3.67, topping expectations of $3.58. The company reiterated its full-year revenue outlook of $6.745B–$6.805B and non-GAAP EPS guidance of $15.11–$15.19.

CEO Sassine Ghazi emphasized mega trends like AI, silicon proliferation, and system complexity as durable tailwinds. Segment-wise, Design Automation remained the majority of revenue at 70%, while Design IP held steady with strong margins (31.2%).

SNPS stock was up modestly in post-market trading.

Key Metrics:

• Revenue: $1.604B vs. $1.59B est.

• Non-GAAP EPS: $3.67 vs. $3.58 est.

• FY25 Revenue Guide: $6.745B–$6.805B (reaffirmed)

• FY25 Non-GAAP EPS Guide: $15.11–$15.19 (reaffirmed)

Synopsys has delivered a series of consistent beats, both on revenue and EPS, and shares have responded with steady upside momentum. Last quarter (Q1 FY25), the company reported $1.65 billion in revenue (+20% YoY) and non-GAAP EPS of $3.56, both comfortably ahead of consensus. Management raised full-year guidance, citing strong demand across EDA and IP segments, particularly tied to AI and 3nm/2nm chip designs.

Q4 FY24 and Q3 also featured strong beats, supported by growing backlog, pricing power, and margin resilience. Post-earnings stock reactions have been mostly positive, with SNPS steadily outperforming the broader software and semiconductor peer groups. However, with shares now near all-time highs, the market is looking for continued margin strength and synergy visibility from the Ansys acquisition to justify further upside. A miss or soft tone on macro conditions could break that streak.

Synopsys enters earnings with momentum and strong buy-side support. The stock is up 14% this month and near record highs, reflecting investor confidence in AI chip design tailwinds and predictable cash flow generation. Analyst sentiment is overwhelmingly bullish, with most firms rating SNPS a Buy and few visible bear cases. But with the stock already priced for high-teens growth and 80%+ gross margins, the room for upside depends on the strength of forward guidance and clarity on the Ansys deal.

What’s priced in now is continued high-single-digit to low-double-digit revenue growth, clean margin execution, and minimal integration risk from Ansys. The stock could break higher if Synopsys beats on EPS and shows clear visibility into 2H bookings, especially in AI-specific workloads. A surprise expansion in licensing or EDA demand tied to generative AI models — or a new design win in hyperscaler silicon — would justify a higher multiple. In this setup, precision and confidence on the call will matter as much as the actual numbers.

Synopsys is well positioned, but shares could break to new highs if the company reports strong EDA segment growth — particularly above 15% YoY — to reinforce its role as a key enabler of AI silicon design. This would validate sector-wide strength seen at Cadence and show Synopsys is capturing the bulk of new AI tape-outs.

Equally important: IP licensing revenue. If that line item shows strength, it suggests Synopsys is monetizing design wins at premium pricing, which could drive upward revisions. Maintaining gross margins above 80%, even with the Ansys integration on the horizon, would reassure investors on profitability durability. But the biggest swing factor may be management’s Ansys commentary — clear guidance on timing, synergy capture, and customer overlap strategy could solidify confidence in the acquisition’s ROI. Add in clean H2 backlog visibility, and SNPS could deliver a breakout quarter.

1. AI-Driven EDA Demand

AI chip design is booming. Investors are watching how much incremental EDA and IP licensing demand Synopsys captures.

2. Ansys Integration Roadmap

The $35B Ansys deal is a bet on simulation + chip synergy. Earnings need to show early strategic logic and timeline.

3. Backlog and Bookings Visibility

Guidance stability hinges on visibility into design cycle demand and customer backlog conversion in H2.

4. Margin Durability

With gross margins above 80%, any sign of erosion — especially during Ansys integration — could spook investors.

5. Geopolitical Exposure

China exposure is a known wildcard. Investors need color on license restrictions and impact from U.S. export controls.